Product NDC: | 99207-270 |
Proprietary Name: | Zyclara |
Non Proprietary Name: | imiquimod |
Active Ingredient(s): | 37.5 mg/g & nbsp; imiquimod |
Administration Route(s): | TOPICAL |
Dosage Form(s): | CREAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 99207-270 |
Labeler Name: | Medicis Pharmaceutical Corp |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022483 |
Marketing Category: | NDA |
Start Marketing Date: | 20111128 |
Package NDC: | 99207-270-28 |
Package Description: | 28 PACKET in 1 CARTON (99207-270-28) > .25 g in 1 PACKET |
NDC Code | 99207-270-28 |
Proprietary Name | Zyclara |
Package Description | 28 PACKET in 1 CARTON (99207-270-28) > .25 g in 1 PACKET |
Product NDC | 99207-270 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | imiquimod |
Dosage Form Name | CREAM |
Route Name | TOPICAL |
Start Marketing Date | 20111128 |
Marketing Category Name | NDA |
Labeler Name | Medicis Pharmaceutical Corp |
Substance Name | IMIQUIMOD |
Strength Number | 37.5 |
Strength Unit | mg/g |
Pharmaceutical Classes | Increased Cytokine Activity [PE],Increased Cytokine Production [PE],Interferon Inducers [MoA] |